Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
EVER
|
Seth Birnbaum
President and CEO |
SELL
Open market or private sale
|
Direct | 10,425 Reduced 2.22% |
$384,370
$36.87 p/Share
|
Sep 28
2020 |
EVER
|
Tomas Revesz Jr
Chief Architect |
SELL
Open market or private sale
|
Direct | 10,425 Reduced 1.91% |
$383,640
$36.8 p/Share
|
Sep 28
2020 |
LOGC
|
Arix Bioscience PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 273,584 Reduced 10.3% |
$2,062,823
$7.54 p/Share
|
Sep 28
2020 |
BDRY
|
Sit Investment Associates Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 61,200 Reduced 100.0% |
$1,225,224
$20.02 p/Share
|
Sep 28
2020 |
BDRY
|
Sit Investment Associates Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 100.0% |
$1,201,200
$20.02 p/Share
|
Sep 28
2020 |
ALKS
|
David W Anstice
Director |
SELL
Open market or private sale
|
Direct | 17,832 Reduced 20.68% |
$299,399
$16.79 p/Share
|
Sep 28
2020 |
DEN
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,200 Reduced 0.15% |
$210,560
$18.8 p/Share
|
Sep 28
2020 |
EXPI
|
Darren Lee Jacklin |
SELL
Open market or private sale
|
Direct | 4,880 Reduced 6.34% |
$195,200
$40.0 p/Share
|
Sep 28
2020 |
ARES
|
David B Kaplan
Co-Founder |
SELL
Open market or private sale
|
Indirect | 35,006 Reduced 1.77% |
$1,373,635
$39.24 p/Share
|
Sep 25
2020 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$3,599,700
$239.98 p/Share
|
Sep 25
2020 |
ADI
|
Gregory N. Henderson
SVP, Atmtve, Comm, ArSpc & Def |
SELL
Open market or private sale
|
Direct | 14,233 Reduced 70.96% |
$1,590,822
$111.77 p/Share
|
Sep 25
2020 |
NKE
|
Elizabeth J Comstock
Director |
SELL
Open market or private sale
|
Direct | 28,000 Reduced 60.3% |
$3,431,400
$122.55 p/Share
|
Sep 25
2020 |
FNF
|
Peter O Shea Jr
Director |
SELL
Open market or private sale
|
Direct | 26,684 Reduced 13.44% |
$831,473
$31.16 p/Share
|
Sep 25
2020 |
FNF
|
Raymond R Quirk
Executive Vice-Chairman |
SELL
Open market or private sale
|
Direct | 131,780 Reduced 26.12% |
$4,097,040
$31.09 p/Share
|
Sep 25
2020 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 0.7% |
$750,023
$67.9 p/Share
|
Sep 25
2020 |
ADBE
|
John E Warnock
Director |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 0.58% |
$1,181,325
$472.53 p/Share
|
Sep 25
2020 |
TDOC
|
William H. Frist |
SELL
Open market or private sale
|
Direct | 740 Reduced 12.02% |
$154,290
$208.5 p/Share
|
Sep 25
2020 |
LSCC
|
John E Major
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 3.12% |
$27,280
$27.28 p/Share
|
Sep 25
2020 |
LSCC
|
John Bourgoin
Director |
SELL
Open market or private sale
|
Direct | 8,665 Reduced 5.18% |
$237,074
$27.36 p/Share
|
Sep 25
2020 |
OBCI
|
Gregor M Dornau
EVP Sales & Marketing |
SELL
Open market or private sale
|
Direct | 932 Reduced 0.2% |
$14,027
$15.05 p/Share
|
Sep 25
2020 |
LOGC
|
Arix Bioscience PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 174,219 Reduced 6.16% |
$1,233,471
$7.08 p/Share
|
Sep 25
2020 |
GH
|
Ian T Clark
Director |
SELL
Open market or private sale
|
Direct | 538 Reduced 10.38% |
$57,157
$106.24 p/Share
|
Sep 25
2020 |
DEN
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 45,204 Reduced 0.29% |
$846,219
$18.72 p/Share
|
Sep 25
2020 |
SSNT
|
Jeffrey D Roth
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.99% |
$12,250
$2.45 p/Share
|
Sep 25
2020 |
EXPI
|
Darren Lee Jacklin |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 4.94% |
$160,000
$40.0 p/Share
|
Sep 25
2020 |
TFFP
|
Glenn R. Mattes
President and CEO |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 30.0% |
$51,000
$17.0 p/Share
|
Sep 25
2020 |
ESSC
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 86,717 Reduced 2.94% |
$855,030
$9.86 p/Share
|
Sep 24
2020 |
CRM
|
Joe Allanson
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 383 Reduced 1.22% |
$90,308
$235.79 p/Share
|
Sep 24
2020 |
CRM
|
Mark J Hawkins
President and CFO |
SELL
Open market or private sale
|
Direct | 1,001 Reduced 7.13% |
$236,026
$235.79 p/Share
|
Sep 24
2020 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$3,556,050
$237.07 p/Share
|
Sep 24
2020 |
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.26% |
$326,650
$65.33 p/Share
|
Sep 24
2020 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$655,000
$65.5 p/Share
|
Sep 24
2020 |
PTC
|
Phillip M Fernandez |
SELL
Open market or private sale
|
Direct | 250 Reduced 1.19% |
$20,315
$81.26 p/Share
|
Sep 24
2020 |
NKE
|
Mark G Parker
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 95,906 Reduced 6.31% |
$12,185,816
$127.06 p/Share
|
Sep 24
2020 |
NKE
|
Monique S. Matheson
EVP: CHRO |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 14.78% |
$3,098,750
$123.95 p/Share
|
Sep 24
2020 |
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,600 Reduced 100.0% |
$2,773,176
$495.21 p/Share
|
Sep 24
2020 |
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 64,542 Reduced 92.02% |
$30,634,860
$474.65 p/Share
|
Sep 24
2020 |
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 38,257 Reduced 0.24% |
$4,973
$0.13 p/Share
|
Sep 24
2020 |
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Sep 24
2020 |
MTEX
|
Alfredo Bala
CEO and President |
SELL
Open market or private sale
|
Direct | 3,510 Reduced 43.93% |
$57,845
$16.48 p/Share
|
Sep 24
2020 |
PGNY
|
Lisa Greenbaum
EVP, Chief Client Officer |
SELL
Open market or private sale
|
Direct | 869 Reduced 14.7% |
$23,263
$26.77 p/Share
|
Sep 24
2020 |
LOGC
|
Arix Bioscience PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 38,514 Reduced 1.34% |
$293,862
$7.63 p/Share
|
Sep 24
2020 |
DEN
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 38,900 Reduced 0.5% |
$737,933
$18.97 p/Share
|
Sep 24
2020 |
DEN
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 12,707 Reduced 0.16% |
$240,035
$18.89 p/Share
|
Sep 24
2020 |
SSNT
|
Jeffrey D Roth
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.98% |
$11,500
$2.3 p/Share
|
Sep 24
2020 |
NFE
|
Nfe Smrs Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 36,060 Reduced 0.1% |
$1,352,971
$37.52 p/Share
|
Sep 24
2020 |
SBGI
|
Howard E Friedman
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 13.66% |
$81,000
$20.25 p/Share
|
Sep 24
2020 |
GMGI
|
Thomas Mcchesney |
SELL
Open market or private sale
|
Direct | 4,467 Reduced 2.68% |
$25,105
$5.62 p/Share
|
Sep 24
2020 |
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 0.31% |
$7,000
$0.14 p/Share
|
Sep 23
2020 |
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Sep 23
2020 |